within Pharmacolibrary.Drugs.ATC.C;

model C01BC08
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.3,
    Cl             = 0.31666666666666665,
    adminDuration  = 600,
    adminMass      = 0.1,
    adminCount     = 1,
    Vd             = 0.0057,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.008333333333333333,
    Tlag           = 0
  );

  annotation(Documentation(
    info ="<html><body><p>Encainide is a class Ic antiarrhythmic agent previously used to treat ventricular arrhythmias, such as ventricular tachycardia. Due to concerns regarding proarrhythmic effects and increased mortality in certain patient populations, it has been withdrawn from the market in many countries and is generally not approved for current clinical use.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are reported for adult patients with normal renal and hepatic function following oral administration.</p><h4>References</h4><ol><li><p>Jaillon, P (1990). Pharmacokinetics and metabolism of encainide. <i>Cardiovascular drugs and therapy</i> 4 Suppl 3 561–565. DOI:<a href=&quot;https://doi.org/10.1007/BF00357031&quot;>10.1007/BF00357031</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2125833/&quot;>https://pubmed.ncbi.nlm.nih.gov/2125833</a></p></li><li><p>Tordjman, T, &amp; Estes, NA (1987). Encainide: its electrophysiologic and antiarrhythmic effects, pharmacokinetics, and safety. <i>Pharmacotherapy</i> 7(5) 149–163. DOI:<a href=&quot;https://doi.org/10.1002/j.1875-9114.1987.tb04042.x&quot;>10.1002/j.1875-9114.1987.tb04042.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3124082/&quot;>https://pubmed.ncbi.nlm.nih.gov/3124082</a></p></li><li><p>Gomoll, AW, et al., &amp; Antonaccio, MJ (1986). Electrophysiology, hemodynamic and arrhythmia efficacy model studies on encainide. <i>The American journal of cardiology</i> 58(5) 10C–17C. DOI:<a href=&quot;https://doi.org/10.1016/0002-9149(86)90098-6&quot;>10.1016/0002-9149(86)90098-6</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/3092614/&quot;>https://pubmed.ncbi.nlm.nih.gov/3092614</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C01BC08;
